Arginase Liver Type Human ELISA

Catalog number: RD193028000R
Brand: BioVendor
Packing: 96 wells
Price: € 510.00
Expected delivery time: 7 days
Quantity:

Product specifications for - Arginase Liver Type Human ELISA

Overview: 
Product group: Assays
Category: ELISA / EIA
Properties: 
Assay Sensitivity: 2,7 ng/ml
Assay Precision: Inter assay: n = 8, CV = 7,8%, Intra assay: n = 8, CV = 5,8%,
Assay Sample Type: serum and cerebrospinal fluid (CSF)
Assay Time: The total assay time is less than 3 hours
Assay Detection Range: 5 - 320 ng/ml
  Research Use Only
UNSPSC: 41116158
Storage instructions: Place the lyophilized Master Standards and Quality Controls at -20-¦C after the kit delivery. Store the other kit components at 2-8-¦C. Under these conditions the kit is stable till the expiry date is over. (See the expiry date indicated on the kit label).
Additional information: 
Synonyms: RD193028000R; BioVendor
Bekpinar S, Gurdol F, Unlucerci Y, Develi S, Yilmaz A. Serum levels of arginase I are associated with left ventricular function after myocardial infarction. Clin Biochem. 2011 Sep,44 (13):1090-3 Read more
Dimitriades V, Rodriguez PC, Zabaleta J, Ochoa AC. Arginase I levels are decreased in the plasma of pediatric patients with atopic dermatitis. Ann Allergy Asthma Immunol. 2014 Sep,113 (3):271-5 Read more
El-Hady SB, Farahat MH, Atfy M, Elhady MA. Nitric oxide metabolites and arginase I levels in beta-thalassemic patients: an Egyptian study. Ann Hematol. 2012 Aug,91 (8):1193-200 Read more
Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother. 2011 Oct,60 (10):1419-30 Read more
Giallongo C, Parrinello N, Tibullo D, La Cava P, Romano A, Chiarenza A, Barbagallo I, Palumbo GA, Stagno F, Vigneri P, Di Raimondo F. Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients. PLoS One. 2014,9 (7):e101848 Read more
Grasemann H, Schwiertz R, Grasemann C, Vester U, Racke K, Ratjen F. Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis. Respir Res . Jun 9,7:87 (2006) Read more
Larkin SK, Morris CR, Styles LA, Kuypers FA. Elevated Plasma Arginase Levels in Hemoglobinopathies. Blood . 106 (11) (2005) Read more
Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008 Jan 1,111 (1):402-10 Read more
Nzoumbou-Boko R, Dethoua M, Gabriel F, Buguet A, Cespuglio R, Courtois P, Daulouede S, Bouteille B, Ngampo S, Mpandzou G, Semballa S, Vincendeau P. Serum arginase, a biomarker of treatment efficacy in human African trypanosomiasis. J Clin Microbiol. 2013 Jul,51 (7):2379-81 Read more
Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009 Feb 15,69 (4):1553-60 Read more